Powering the next generation of digital pathology labs.
AISight® is a cloud-native digital pathology Image Management System (IMS) that powers enterprise workflows and AI applications for leading laboratories and research centers. It serves as a central hub for case management, image management, and best-in-class artificial intelligence tools to enable multiple histopathology use cases.
Automates data organization, flags samples of interest, and simplifies batch processing, reducing manual steps and helping research teams handle large study datasets more efficiently
Enhance Collaboration
Enables interdisciplinary communication and teamwork with real-time consultation tools such as AISight Live, improving collaboration on complex cases
AI-Native Image Management System
Direct integration of AI algorithms into the platform enables next-generation workflow efficiencies, such as smart case prioritization and intelligent case management
Versatile Functionality
Supports a wide range of use cases — including workflow optimization, histopathology research, and training — streamlining workflows and eliminating the need for multiple systems
Discover how AISight can boost efficiency, streamline research workflows, and transform your operations. Download our white paper to learn more.
AISight further comes with the industry's largest menu of state-of-the-art and out-of-the-box algorithms across research, workflow optimization, assisted scoring, and biomarker quantification, and assistants use cases embedded directly into the IMS.
ARTIFACT DETECT: Automated detection of artifact by action-oriented classes (Scanning, Cover slipping, Sectioning, Grossing and Other) to monitor quality
TUMOR DETECT: Automated detection of tumor across all common carcinomas for case prioritization and case triaging
AIM TUMOR CELLULARITY: Automate tumor-cellularity assessment for molecular testing workflows
AIM IHC BREAST PANEL: Automated scoring of major Breast Cancer biomarkers (HER2, ER, PR, Ki67) following ASCO/CAP guidelines
MET PREDICT: AI-powered insights on molecular alteration status of specimen, based on H&E images, enhancing the molecular testing prioritization
PATH ASSIST DERM: AI-powered classification of dermatopathology neoplasms and inflammatory lesions.
AIM MASH: Automated MASH CRN Scoring along with representation of hepatocellular ballooning, fibrosis, lobular inflammation, portal inflammation, and interface hepatitis
AIM PDL1: Automated scoring of PD-L1 positivity in tumor and immune cells for NSCLC, Urothelial Carcinoma, HNSCC, and Melanoma
AIM-HI Ulcerative Colitis: Automated Geboes Scoring for inflammation severity within cases with known ulcerative colitis
AISight Multi-Partner AI Portfolio
PathAI’s AISight platform offers an integrated ecosystem of world-class AI algorithms developed by top-tier partners, bringing innovative tools to pathology labs of all sizes and specialties. With the AISight Multi-Partner AI Portfolio, pathologists have seamless access to a diverse array of high-performance digital pathology solutions—all within the AISight.
Trusted Worldwide
AISight is trusted by some of the world’s leading pathology laboratories and life science organizations to support high-throughput, AI-enabled research. The platform processes over 5 million whole-slide images annually, enabling scalable, efficient, and accurate digital pathology workflows that accelerate discovery and innovation across global institutions.
CASE STUDY
AI-Assisted Titer Selection in Early Assay Development
PathAI deployed IHC Explore on prostate cancer specimens stained with a novel, in-development assay
IHC Explore quantifies staining intensity at single-cell resolution, enabling rapid assay characterization and titer optimization
Continuous staining intensity measurement provides added value for next-generation biomarkers and precision medicine strategies
Explore how AISight is transforming pathology through global partnerships, access the latest updates in our Newsroom.
Schedule a free demo today
fuel your pathology workflows & research with AISight
AISight® is for Research Use Only in the US. Artifact Detect is a workflow tool on AISight. Tumor Detect, AIM-Tumor Cellularity, AIM-MASH, AIM IHC Breast Panel, MET Predict, PathAssist Derm, AIM-HI UC, AIM PDL1 are for research use only. Not for use in diagnostic procedures.
.png?width=2000&height=2000&name=Landing%20page%20header%20use%20graphic%20(1).png)
.png?width=2000&height=1035&name=RUO%20-%20full%20screen%20(1).png "RUO - full screen (1)")
-1.png?width=1200&length=1200&name=DONE%20AISIght%20Brochure%20(3)-1.png)
-1.png?width=1200&length=1200&name=DONE%20AISIght%20Brochure%20(6)-1.png)
-1.png?width=1200&length=1200&name=DONE%20AISIght%20Brochure%20(5)-1.png)
-1.png?width=1200&length=1200&name=DONE%20AISIght%20Brochure%20(7)-1.png)
.png?width=1200&length=1200&name=DONE%20AISIght%20Brochure%20(8).png)
-1.png?width=1200&length=1200&name=DONE%20AISIght%20Brochure%20(1)-1.png)
-1.png?width=1200&length=1200&name=DONE%20AISIght%20Brochure%20(2)-1.png)
-1.png?width=1200&length=1200&name=DONE%20AISIght%20Brochure%20(4)-1.png)
.png?width=800&height=400&name=DDx%20Commercial%20Customer%20(approved%20use%200725).png "DDx Commercial Customer (approved use 0725)")